Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
-3.06%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$74.9B
AUM Growth
-$4.71B
(-5.9%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
33.9%
Holding
3,045
New
667
Increased
886
Reduced
838
Closed
563
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$713M |
| 2 |
Danaher
DHR
|
+$648M |
| 3 |
Intuit
INTU
|
+$557M |
| 4 |
Costco
COST
|
+$419M |
| 5 |
Tesla
TSLA
|
+$305M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$725M |
| 2 |
Uber
UBER
|
+$550M |
| 3 |
UnitedHealth
UNH
|
+$536M |
| 4 |
Johnson & Johnson
JNJ
|
+$522M |
| 5 |
Apple
AAPL
|
+$427M |
Sector Composition
| 1 | Technology | 19.36% |
| 2 | Consumer Discretionary | 15.1% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 8.07% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Monopar Therapeutics
MNPR
$304M
| $946K | ﹤0.01% |
+25,988
| New | +$946K |
|
|
TECX
1677
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $945K | ﹤0.01% |
+53,340
| New | +$945K |
|
|
MCHB
1678
Mechanics Bancorp Class A Common Stock
MCHB
$3.03B
| $939K | ﹤0.01% |
80,021
+38,358
| +92% | +$450K |
|
|
BPMC
1679
DELISTED
Blueprint Medicines
BPMC
| $938K | ﹤0.01% |
10,600
-151,282
| -93% | -$13.4M |
|
1680
Apollo Global Management
APO
$79B
| $937K | ﹤0.01% |
+6,846
| New | +$937K |
|
1681
Ondas Holdings
ONDS
$2.14B
| $937K | ﹤0.01% |
875,468
+551,008
| +170% | +$590K |
|
1682
Franklin Covey
FC
$240M
| $936K | ﹤0.01% |
+33,899
| New | +$936K |
|
1683
KalVista Pharmaceuticals
KALV
$708M
| $934K | ﹤0.01% |
80,965
-37,013
| -31% | -$427K |
|
|
XYF
1684
X Financial
XYF
$579M
| $934K | ﹤0.01% |
+64,924
| New | +$934K |
|
1685
Steris
STE
$24.6B
| $929K | ﹤0.01% |
4,100
-166,687
| -98% | -$37.8M |
|
1686
Avita Medical
RCEL
$123M
| $929K | ﹤0.01% |
+114,092
| New | +$929K |
|
1687
Integral Ad Science
IAS
$1.4B
| $928K | ﹤0.01% |
+115,127
| New | +$928K |
|
1688
Madrigal Pharmaceuticals
MDGL
$9.63B
| $927K | ﹤0.01% |
2,800
-14,694
| -84% | -$4.87M |
|
1689
Surgery Partners
SGRY
$2.8B
| $926K | ﹤0.01% |
+38,971
| New | +$926K |
|
1690
Synchrony
SYF
$28B
| $920K | ﹤0.01% |
17,371
-85,480
| -83% | -$4.53M |
|
1691
Madison Square Garden
MSGS
$5.12B
| $917K | ﹤0.01% |
4,711
-699
| -13% | -$136K |
|
1692
Acrivon Therapeutics
ACRV
$47.8M
| $914K | ﹤0.01% |
450,391
-147,403
| -25% | -$299K |
|
|
ECG
1693
Everus Construction Group, Inc.
ECG
$4.01B
| $914K | ﹤0.01% |
24,642
-82,859
| -77% | -$3.07M |
|
|
ATSG
1694
DELISTED
Air Transport Services Group, Inc.
ATSG
| $910K | ﹤0.01% |
40,555
+21,523
| +113% | +$483K |
|
1695
Bunge Global
BG
$16.3B
| $909K | ﹤0.01% |
+11,890
| New | +$909K |
|
|
MTA
1696
Metalla Royalty & Streaming
MTA
$527M
| $908K | ﹤0.01% |
317,657
-30,628
| -9% | -$87.6K |
|
1697
Moelis & Co
MC
$5.54B
| $907K | ﹤0.01% |
+15,543
| New | +$907K |
|
1698
Arcutis Biotherapeutics
ARQT
$2.07B
| $906K | ﹤0.01% |
+57,908
| New | +$906K |
|
1699
Chemung Financial Corp
CHMG
$252M
| $905K | ﹤0.01% |
19,018
+8,495
| +81% | +$404K |
|
1700
Sanara MedTech
SMTI
$302M
| $904K | ﹤0.01% |
29,274
-1,011
| -3% | -$31.2K |
|